migraine
Conditions
Interventions
control group:Sham acupuncture
Sponsors
Chengdu University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: 1. Age is between 18-55 years old (the starting age is less than 50 years old), and the gender is not limited; the time of compulsory education >= 6 years; 2. Meet the ICHD-3 diagnostic criteria for migraine without aura; 3. In the past three months, the number of monthly attacks is greater than or equal to 2 times, and the number of headache days is less than 15 days per month; 4. Headache in patients at baseline is regarded as moderate headache (average VAS score 3-7); 5. have a history of migraine for more than one year; 6. Those who can complete the headache diary at the baseline period; 7. The patient himself signs the informed consent. (Only patients who meet the above 7 items can be included in this study).
Exclusion criteria
Exclusion criteria: 1. Patients with other primary headaches and headaches of unknown diagnosis; 2. Combined with serious primary diseases such as cardiovascular and cerebrovascular, liver, kidney and hematopoietic systems and other organic diseases; 3. People with a history of head trauma and mental and intellectual disabilities who cannot cooperate with the questionnaire; 4. Those with bleeding tendency, allergies and skin diseases; 5. Pregnant women and lactating women, those who have fertility requirements in the past six months; 6. Can't understand or record the headache diary; 7. Having the habit of taking analgesics and alcohol for a long time; 8. Received acupuncture treatment or other preventive treatment in the last 4 weeks; 9. Those who have participated in similar researches within 3 months. (Anyone who meets any of the above should be excluded).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of migraine attacks; | — |
Secondary
| Measure | Time frame |
|---|---|
| Days of migraine attack;Intensity of migraine;Headache duration (hours);Percentage of patients taking acute analgesic;Treatment response rate;Migraine Specific Quality of Life Question, MSQ;Headache impact scale (HIT-6);TCM syndrome assessment scale;Patient treatment satisfaction evaluation;Calcitonin Gene related Peptide, CGRP; | — |
Countries
China
Contacts
Public ContactLing Zhao
Chengdu University of Traditional Chinese Medicine
Outcome results
None listed